2 great FTSE 100 stocks to own heading into a recession

Jabran Khan identifies two FTSE 100 stocks he feels are recession-proof and details their defensive capabilities.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young brown woman delighted with what she sees on her screen

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Many believe that a recession could be on the cards. With that in mind, I am on the lookout for the best FTSE 100 stocks for my holdings.

I have identified two I believe could be great picks. Let’s take a closer look at them.

Healthcare

My first pick is GlaxoSmithKline (LSE:GSK). It is one of the world’s biggest healthcare businesses developing and selling medicines and vaccines with a global footprint.

Healthcare stocks are often seen as recession-proof due to their defensive and essential nature. No matter the state of the economy, people need healthcare and medicines. Furthermore, the pandemic shone a new light on the importance of health and well-being in the past couple of years.

So what’s happening with GlaxoSmithKline shares currently? They’re trading for 1,786p, as I write. At this time last year, the shares were trading for 1,419p, which is a 25% increase over a 12-month period.

Although arguably recession-proof, Glaxo stock does have risks. Current macroeconomic headwinds such as the rising cost of materials and the supply chain crisis could negatively impact operations, performance and returns. These issues are affecting many FTSE 100 stocks, however

As well as GlaxoSmithKline’s defensive capabilities, it has a good track record of performance in recent years. I do understand that past performance is not a guarantee of the future, however. Positive performance and profits leads to investor returns in the form of dividends that could boost my passive income stream. Glaxo’s current dividend yield is 4.3%, higher than the FTSE 100 average of 3%-4%.

I would add GlaxoSmithKline shares to my holdings heading into a recession. Its profile, presence, performance record, as well as the passive income opportunity are too good to miss. It also has an excellent pipeline of drugs, which should support future growth.

Utilities

My next pick is National Grid (LSE:NG). It is the UK’s electricity system operator providing the population with power. In addition to this, in the US it powers 20m customers across Massachusetts, New York and Rhode Island.

Like healthcare, utilities are also often seen as defensive stocks in times of economic uncertainty. Power is one of the modern-day essentials for our homes and businesses after all.

So what’s happening with the National Grid share price currently? Well, as I write, they are trading for 1,080p. At this time last year, the stock was trading for 920p, which is a 17% increase over a 12-month period.

National Grid shares have risks, too. I did notice that it has a significant amount of debt on its balance sheet. Due to rising interest rates, this debt could become costlier to service. In turn, this could affect investor returns and sentiment.

The firm also has a good record of performance. This performance underpins a healthy dividend yield of close to 5%. Utility stocks are often seen as passive income safe-havens. It is worth noting, though, dividends can be cancelled at the discretion of the business at any time. This tends to happen more so during difficult economic periods or extreme events such as a pandemic.

I would happily add National Grid shares to my holdings, and view them as a defensive option for my portfolio for any impending recession.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Jabran Khan has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »